POLYCILLIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Polycillin, and when can generic versions of Polycillin launch?
Polycillin is a drug marketed by Bristol and Apothecon and is included in seven NDAs.
The generic ingredient in POLYCILLIN is ampicillin/ampicillin trihydrate; probenecid. Additional details are available on the ampicillin/ampicillin trihydrate; probenecid profile page.
Summary for POLYCILLIN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 76 |
Formulation / Manufacturing: | see details |
DailyMed Link: | POLYCILLIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for POLYCILLIN
US Patents and Regulatory Information for POLYCILLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol | POLYCILLIN | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 050310-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol | POLYCILLIN | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 050308-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apothecon | POLYCILLIN | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 062297-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |